Prostanoids in human colonic mucosa: Effects of inflammation on PGE2 receptor expression

Human Immunology

Volumn 61, Issue 7, 2000, Pages 684-696

  Cosme, Rosana ^a   Lublin, Darienne ^a   Takafuji, Vivian ^a   Lynch, Kevin ^a   Roche, James K ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

Inflammation; Mucosa; Prostanoids; Receptors

Indexed keywords

IMMUNOGLOBULIN; INTERLEUKIN 2; MESSENGER RNA; PROSTAGLANDIN E2; PROSTANOID; RECEPTOR;

ARTICLE; BINDING AFFINITY; COLON MUCOSA; CONTROLLED STUDY; CYTOKINE RELEASE; DENSITOMETRY; FLOW CYTOMETRY; FLUORESCENCE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LAMINA PROPRIA; LYMPHOCYTE FUNCTION; MUCOSA INFLAMMATION; PRIORITY JOURNAL; PROSTAGLANDIN RELEASE; RNA PROBE;

AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; COLITIS; COLON; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; DINOPROSTONE; GENE EXPRESSION; HUMANS; INTERLEUKIN-2; INTESTINAL MUCOSA; INTESTINAL SECRETIONS; ISOENZYMES; MEMBRANE PROTEINS; MOLECULAR SEQUENCE DATA; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; PROSTAGLANDINS; RABBITS; RECEPTORS, PROSTAGLANDIN E; RNA, MESSENGER;

EID: 0033936607     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0198-8859(00)00131-2     Document Type: Article

References (30)

1. Sharon P., Ligumsky M., Rachmilewitz D., Zor U. Role of prostaglandins in ulcerative colitis enhanced production during active disease and inhibition by sulfasalazine . Gastroenterology. 75:1978;638.
2. 2 release and its relation to disease activity, electrical potential difference, and treatment in ulcerative colitis. Gut. 21:1980;591.
3. 2 from activated eosinophils and macrophages in ulcerative colitis. Am J Gastroenterol. 90:1995;614.
4. Coleman C.A., Smith W.L., Norumiya S. Classification of prostanoid receptors properties, distribution and structure of the receptors and their subtypes . Pharmacol Rev. 46:1994;205.
5. Neu J., Hoffman R.G., Cram W.N. Prostaglandin-mediated effects on growth and markers of biochemical development in the rat. Pediatr Res. 17:1983;537.
6. Goodlad R.A., Lee C.Y., Levin S., Wright N.A. Effect of the prostaglandin analogue misoprostol on cell proliferation in the canine small intestine. Exp Physiol. 76:1991;561.
7. 2 of interleukin release by T lymphocytes in mucosa. J Cell Physiol. 166:1996;130.
8. Garland C.F., Lilienfeld A.M., Mandeloff A.I., Markowitz M., Terrell K.B., Garland F.C. Incidence rates of ulcerative colitis and Crohn's disease in fifteen areas of the United States. Gastroenterology. 81:1981;1115.
9. Morson B.C. Pathology of ulcerative colitis. Kirsner J., Shorter R. Inflammatory Bowel Diseases. First edn :1980;Lea & Febiger, Philadelphia.
10. Schreihofer A.M., Guyenet P.G. Identification of C1 presympathetic neurons in rat rostral ventrolateral medulla by juxtracellular labelling in vivo. J Comp Neurol. 387:1997;524.
11. Bull D.M., Bookman M.A. Isolation and functional characterization of human intestinal mucosal lymphoid cells. J Clin Invest. 59:1977;966.
12. Roche J.K., Fiocchi C., Youngman K. Sensitization to epithelial antigens in chronic mucosal inflammatory disease. J Clin Invest. 75:1985;522.
13. Fiocchi C. Mucosal cellular immunity. Target S.R., Shanahan E. Immunology and Immunopathology of the Liver and the Gastrointestinal Tract . 1990;Igaqu-Shoin Co, New York.
14. Harvey J., Jones D.B., Wright D.H. Leucocyte common antigen expression on T cells in normal and inflamed gut. Immunology. 68:1989;13.
15. Trejdosiewcz L.K., Smart C.J., Oakes D.J., Howdle P.D., Malizia G., Campana D., Boylstons A.W. Expression of T-cell receptors TcR1 (γ/δ) and TcR2 (α/β) in the human intestinal mucosa. Immunology. 68:1989;7.
16. 2 cytokine profile in the intestinal mucosa of patients with inflammatory bowel disease, as assessed by quantitative reversed transcribed polymerase chain reaction (RT-PCR). Clin Exp Immunol. 101:1995;428.
17. Eberhart C.E., Dubois R.N. Eicosanoids and the gastrointestinal tract. Gastroenterology. 109:1995;185.
18. Geotzel E.J., Lewis R.A., Rola-Pleszczynski M. Cellular Generation, Transport, and Effects of Eicosanoids Biological Roles and Pharmacological Intervention . 1994;Academy of Sciences, New York, NY.
19. Madara J.L., Stafford J. Interferon-γ directly affects barrier functions of cultured intestinal epithelial monolayers. J Clin Invest. 83:1989;724.
20. Adams R.B., Planchon S.M., Roche J.K. Gamma interferon modulation or epithelial barrier function time course, reversibility and site of cytokine binding . J Immunol. 150:1993;2356.
21. Planchon S., Fiocchi C., Takafuji V., Roche J.K. Transforming growth factor β1 preserves epithelial barrier function identification of receptors, biochemical intermediaries, and cytokine antagonists . J Cell Physiol. 181:1999;55.
22. Schreiber S., MacDermott R.P., Raedler A., Pinnau R., Bertovich M.J., Nash G.S. Increased activation of isolated intestinal lamina propria mononuclear cells in inflammatory bowel disease. Gastroenterology. 101:1991;1020.
23. Fiocchi C., Hilfiker M.L., Youngman K.R. Interleukin 2 activity of human intestinal mucosal mononuclear cells Decreased levels in inflammatory bowel disease . Gastroenterology. 86:1984;734.
24. James S.P., Fiocchi C., Graeff A.S. Phenotypic analysis of lamina propria lymphocytes. Gastroenterology. 91:1986;483.
25. Lieberman B.Y., Fiocchi C., Youngman K.R. Interferon gamma production by human intestinal mucosal mononuclear cells Decreased levels in inflammatory bowel disease . Dig Dis Sci. 33:1988;1297.
26. Breese E, Braegger CP, Corrigan CT. Interleukin-2- and interferon-gamma-secretary T cells in normal and diseased human intestinal mucosa. Immunology 78:127, 1993.
27. Kelsen H.B., Ramessen J.J., Quortrup K. Prostaglandin H synthase immunoreactivity in human gut . Histochemistry. 96:1991;295.
28. Zifronic A., Treves A.J., Sachar D.B., Rachmilewitz D. Prostanoid synthesis by cultured intestinal epithelial and mononuclear cells in inflammatory bowel disease. Gut. 24:1982;659.
29. Singer I.I., Kawka D.W., Schloemann S., Tessner T., Riebl T., Stenson W.F. Cyclooxygenase 2 is induced in colonice epithelial cell in inflammatory bowel disease. Gastroenterology. 115:1998;297.
30. Crofford L.J., Wilder R.L., Ristimaki A.P., Sano H., Remmers E.F., Epps H.P., Hia T. Cyclooxygenase-1 and -2 expression in rheumatoid synovial tissues. J Clin Invest. 93:1994;1095.